Cargando…

Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment

INTRODUCTION: Though double-blind studies have indicated that hydromorphone and diacetylmorphine produce similar effects when administered through injectable opioid agonist treatment (iOAT) programs, participant preference may influence some aspects of medication dispensation such as dose. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blawatt, Sarin, Arreola, Lourdes Atziri Gonzalez, Magel, Tianna, MacDonald, Scott, Harrison, Scott, Schechter, Martin T., Oviedo-Joekes, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140796/ https://www.ncbi.nlm.nih.gov/pubmed/37124402 http://dx.doi.org/10.1016/j.abrep.2023.100490

Ejemplares similares

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
por: Adams, Alison, et al.
Publicado: (2023)

“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises
por: Jaffe, Kaitlyn, et al.
Publicado: (2023)

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review
por: Adams, Alison, et al.
Publicado: (2023)

Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study
por: Dobischok, Sophia, et al.
Publicado: (2022)

Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2020)

Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2023)

The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC
por: Dobischok, Sophia, et al.
Publicado: (2023)

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
por: Palis, Heather, et al.
Publicado: (2021)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency
por: Marchand, Kirsten I, et al.
Publicado: (2011)

The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2015)

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment
por: Palis, Heather, et al.
Publicado: (2021)

Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2019)

Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2021)

The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users
por: Marchand, Kirsten, et al.
Publicado: (2015)

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder
por: Palis, Heather, et al.
Publicado: (2017)

Patient-centred care for addiction treatment: a scoping review protocol
por: Marchand, Kirsten, et al.
Publicado: (2018)

Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review
por: Marchand, Kirsten, et al.
Publicado: (2019)

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder()
por: Palis, Heather, et al.
Publicado: (2018)

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2014)

NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America
por: Gartry, Candice C, et al.
Publicado: (2009)

Feasibility of Applying the Life History Calendar in a Population of Chronic Opioid Users to Identify Patterns of Drug Use and Addiction Treatment
por: Fikowski, Jill, et al.
Publicado: (2014)

A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study
por: Trujols, Joan, et al.
Publicado: (2014)

“It feels like I’m coming to a friend’s house”: an interpretive descriptive study of an integrated care site offering iOAT (Dr. Peter Centre)
por: Dobischok, Sophia, et al.
Publicado: (2023)

Aligning Training and Client Expectations
por: Brenner, Michael
Publicado: (2014)

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients
por: Mahu, Ioan T., et al.
Publicado: (2023)

Prevalence of alcohol consumption among clients of opioid agonist treatment (OAT) centers in Golestan province, Iran
por: Noroozi, Alireza, et al.
Publicado: (2023)

Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients
por: Zahra, Emma, et al.
Publicado: (2022)

A chance to stop and breathe: participants’ experiences in the North American Opiate Medication Initiative clinical trial
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2014)

The prevalence of and exact indications for daily opioid use among aged home care clients with and without dementia
por: Mörttinen-Vallius, Heidi, et al.
Publicado: (2020)

The Development and Validation of the Client Expectations of Massage Scale
por: Boulanger, Karen T., et al.
Publicado: (2012)

Patients'/Clients' Expectation Toward and Satisfaction from Pharmacy Services
por: Ayalew, Mohammed Biset, et al.
Publicado: (2017)

The Cedar Project: resilience in the face of HIV vulnerability within a cohort study involving young Indigenous people who use drugs in three Canadian cities
por: Pearce, Margo E., et al.
Publicado: (2015)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Factors associated with daily opioid use among aged home care clients: a cross-sectional analysis of Resident Assessment Instrument data
por: Mörttinen-Vallius, Heidi, et al.
Publicado: (2021)

Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients’ perspective
por: Granerud, Arild, et al.
Publicado: (2015)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Probation clients’ barriers to access and use of opioid use disorder medications
por: Reichert, Jessica, et al.
Publicado: (2019)

Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
por: Winhusen, Theresa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nq6hm6tlphqc6mn9fajg9mjph3